Elon Musk’s Neuralink to Implant ‘Blindsight’ Chip in First Human by 2025 April 3, 2025 Elon Musk announces Neuralink’s first human trial by the end of 2025 for the Blindsight implant, designed to restore vision for blind individuals.
Neuralink Seeks Trademarks for ‘Blindsight,’ ‘Telepathy,’ & ‘Telekinesis’ April 1, 2025 Neuralink has filed for trademarks on ‘Blindsight,’ ‘Telepathy,’ and ‘Telekinesis,’ aligning with its brain-computer interface projects aimed at restoring vision and enabling mind-controlled devices.
This Week in Healthtech: Brain Implants, AI Partnerships, & a Billion-Dollar IPO January 18, 2025 What a week it’s been in the world of healthcare innovation. From brain-computer interfaces making waves to billion-dollar IPO buzz, there’s plenty to unpack. So grab a coffee, and let’s dive into the top headlines of the week!
Neuralink Implants 3rd Human Patient, Expands Trials for 2025 January 13, 2025 Neuralink has implanted its device in a third patient and plans more procedures in 2025. Its FDA-approved studies focus on using brain-computer interfaces to assist individuals with neurological conditions like paralysis.
Neuralink Receives Approval for New Brain Implant Feasibility Study November 26, 2024 Neuralink announced that it has received approval to launch a new feasibility study to evaluate its brain implant and experimental robotic arm.
Elon Musk’s Brain Chip Startup Gains Approval for Trials in Canada November 21, 2024 Elon Musk's Neuralink secures approval for brain chip trials in Canada, aiming to help paralyzed individuals control digital devices through thought.
Neuralink’s ‘Blindsight’ Device Receives FDA Approval to Restore Vision September 18, 2024 The device is designed to enable individuals who have lost both eyes and their optic nerves to see again.
Neuralink's 2nd Human Implant Surgery a Success, Expanding Brain-Computer Interface Capabilities August 23, 2024 Neuralink’s Link device currently allows users to control on-screen cursors and digital devices.
Neuralink Implants Second Brain Chip, Musk Says Trial “Gone Extremely Well” August 5, 2024 According to the billionaire, 400 of the implant’s electrodes on the second patient’s brain are functioning. Further, the startup’s website states that its implant uses 1,024 electrodes.
Neuralink's Brain Chip Wires Stable in 1st Patient, Says Company July 15, 2024 Neuralink, Elon Musk's brain chip company has recently announced that the tiny wires of Neuralink's brain chip implant used in the first participant of a trial run have become "more or less very stable," a company executive said on Wednesday.
Neuralink Begins Human Trials with Brain-Computer Interface June 3, 2024 Initially, Neuralink sought to enroll ten patients for its clinical trials, as reported by Reuters last year.
After Issues with 1st, FDA Now Approves 2nd Neuralink Implant May 21, 2024 To remedy the complications of the initial implant, the company plans to embed some of the device's wires deeper into the brain.